INR 1906.7
(-3.07%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 2.17 Billion INR | 0.0% |
2022 | 4.07 Billion INR | 15.44% |
2021 | 3.52 Billion INR | 26.13% |
2020 | 2.79 Billion INR | 29.19% |
2019 | 2.16 Billion INR | 45.01% |
2018 | 1.49 Billion INR | 20.62% |
2017 | 1.23 Billion INR | 29.13% |
2016 | 958.98 Million INR | 368.36% |
2015 | 204.75 Million INR | -68.73% |
2014 | 654.77 Million INR | 95.93% |
2013 | 334.18 Million INR | 52.0% |
2012 | 219.86 Million INR | 9.02% |
2011 | 201.67 Million INR | 137.53% |
2010 | 84.9 Million INR | 7.17% |
2009 | 79.22 Million INR | 14.84% |
2008 | 68.98 Million INR | -26.55% |
2007 | 93.92 Million INR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 815.2 Million INR | -18.38% |
2023 Q2 | 1.2 Billion INR | 18.46% |
2023 Q3 | 1.17 Billion INR | -2.75% |
2023 Q4 | 998.8 Million INR | -14.64% |
2023 Q1 | 1.01 Billion INR | 1.69% |
2023 FY | 4.07 Billion INR | 0.0% |
2022 Q2 | 994.5 Million INR | 1.59% |
2022 Q4 | 998.8 Million INR | -9.39% |
2022 FY | 4.07 Billion INR | 15.44% |
2022 Q1 | 978.9 Million INR | 11.7% |
2022 Q3 | 1.1 Billion INR | 10.84% |
2021 Q1 | 839 Million INR | 26.86% |
2021 Q2 | 883 Million INR | 5.24% |
2021 Q3 | 931 Million INR | 5.44% |
2021 Q4 | 876.4 Million INR | -5.86% |
2021 FY | 3.52 Billion INR | 26.13% |
2020 Q1 | 686.4 Million INR | 28.52% |
2020 Q2 | 692.1 Million INR | 0.83% |
2020 Q4 | 661.33 Million INR | -12.79% |
2020 Q3 | 758.3 Million INR | 9.57% |
2020 FY | 2.79 Billion INR | 29.19% |
2019 Q4 | 534.06 Million INR | -13.52% |
2019 Q1 | 473.76 Million INR | 17.08% |
2019 Q2 | 540.63 Million INR | 14.11% |
2019 FY | 2.16 Billion INR | 45.01% |
2019 Q3 | 617.54 Million INR | 14.23% |
2018 Q1 | 347.9 Million INR | -10.06% |
2018 Q3 | 387.25 Million INR | 9.44% |
2018 Q4 | 404.65 Million INR | 4.49% |
2018 FY | 1.49 Billion INR | 20.62% |
2018 Q2 | 353.86 Million INR | 1.71% |
2017 Q3 | 276.39 Million INR | 7.49% |
2017 Q1 | 240.87 Million INR | -11.5% |
2017 FY | 1.23 Billion INR | 29.13% |
2017 Q4 | 386.8 Million INR | 39.95% |
2017 Q2 | 257.14 Million INR | 6.76% |
2016 Q1 | 194.42 Million INR | -8.66% |
2016 FY | 958.98 Million INR | 368.36% |
2016 Q4 | 272.17 Million INR | -10.93% |
2016 Q3 | 305.58 Million INR | 46.71% |
2016 Q2 | 208.29 Million INR | 7.13% |
2015 Q1 | 225.93 Million INR | 49.02% |
2015 Q2 | 158.56 Million INR | -29.82% |
2015 Q4 | 212.85 Million INR | 22.95% |
2015 FY | 204.75 Million INR | -68.73% |
2015 Q3 | 173.11 Million INR | 9.18% |
2014 Q2 | 138.15 Million INR | -8.74% |
2014 Q3 | 139.96 Million INR | 1.31% |
2014 FY | 654.77 Million INR | 95.93% |
2014 Q1 | 151.38 Million INR | 123.33% |
2014 Q4 | 151.61 Million INR | 8.32% |
2013 Q2 | 56.03 Million INR | -43.7% |
2013 Q4 | 67.78 Million INR | 8.23% |
2013 FY | 334.18 Million INR | 52.0% |
2013 Q1 | 99.53 Million INR | 123.26% |
2013 Q3 | 62.62 Million INR | 11.77% |
2012 Q2 | 36.96 Million INR | -65.17% |
2012 Q1 | 106.12 Million INR | 239.94% |
2012 Q4 | 44.58 Million INR | 14.95% |
2012 FY | 219.86 Million INR | 9.02% |
2012 Q3 | 38.78 Million INR | 4.93% |
2011 Q2 | 26.37 Million INR | 0.0% |
2011 FY | 201.67 Million INR | 137.53% |
2011 Q4 | 31.21 Million INR | -33.55% |
2011 Q3 | 46.98 Million INR | 78.14% |
2010 FY | 84.9 Million INR | 7.17% |
2009 FY | 79.22 Million INR | 14.84% |
2008 FY | 68.98 Million INR | -26.55% |
2007 FY | 93.92 Million INR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Albert David Limited | 1.02 Billion INR | -111.909% |
Alembic Limited | 872.45 Million INR | -149.238% |
Alembic Pharmaceuticals Limited | 15.86 Billion INR | 86.298% |
Bafna Pharmaceuticals Limited | 455.58 Million INR | -377.298% |
Bajaj HealthCare Limited | 985.34 Million INR | -120.684% |
Hester Biosciences Limited | 908.84 Million INR | -139.261% |
FDC Limited | 3.49 Billion INR | 37.867% |
Glenmark Life Sciences Limited | 11.64 Billion INR | 81.32% |
Gufic Biosciences Limited | 1.18 Billion INR | -83.256% |
Hikal Limited | 4.46 Billion INR | 51.286% |
Ind-Swift Laboratories Limited | 2.12 Billion INR | -2.369% |
Ind-Swift Limited | 946.56 Million INR | -129.725% |
Innova Captab Limited | 931.03 Million INR | -133.559% |
IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | 1.204% |
Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | -395.839% |
Jubilant Pharmova Limited | 14.45 Billion INR | 84.956% |
Kilitch Drugs (India) Limited | 412.42 Million INR | -427.245% |
Lupin Limited | 125.09 Billion INR | 98.262% |
Morepen Laboratories Limited | 1.98 Billion INR | -9.412% |
Solara Active Pharma Sciences Limited | 2.55 Billion INR | 14.862% |
Themis Medicare Limited | 1.12 Billion INR | -93.152% |
Vaishali Pharma Limited | 84.02 Million INR | -2487.797% |
Venus Remedies Limited | 1.91 Billion INR | -13.475% |
ZIM Laboratories Limited | 1.01 Billion INR | -114.647% |
Alkem Laboratories Limited | 32.83 Billion INR | 93.377% |
Laurus Labs Limited | 11.9 Billion INR | 81.742% |
Lincoln Pharmaceuticals Limited | 1.07 Billion INR | -102.432% |
Mangalam Drugs & Organics Limited | 162.22 Million INR | -1240.397% |
Medico Remedies Limited | 59.67 Million INR | -3543.904% |
Nectar Lifesciences Limited | 932.7 Million INR | -133.14% |
Orchid Pharma Limited | 800.77 Million INR | -171.551% |
Procter & Gamble Health Limited | 2.99 Billion INR | 27.405% |
RPG Life Sciences Limited | 1.63 Billion INR | -32.956% |
Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 98.59% |
Suven Pharmaceuticals Limited | 1.4 Billion INR | -55.013% |
Unichem Laboratories Limited | 6.72 Billion INR | 67.67% |
Wanbury Limited | 978.96 Million INR | -122.122% |
Windlas Biotech Limited | 1 Billion INR | -116.044% |
Ipca Laboratories Limited | 18.98 Billion INR | 88.548% |
Aarti Drugs Limited | 1.16 Billion INR | -86.256% |
Aarti Pharmalabs Limited | 3.07 Billion INR | 29.271% |
Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -31784.164% |
Brooks Laboratories Limited | 51.18 Million INR | -4148.73% |
Eris Lifesciences Limited | 4.94 Billion INR | 56.008% |
Sigachi Industries Limited | 579.88 Million INR | -274.987% |
Sakar Healthcare Limited | 204.07 Million INR | -965.519% |
Aurobindo Pharma Limited | 55.65 Billion INR | 96.093% |
Divi's Laboratories Limited | 14.17 Billion INR | 84.654% |
AstraZeneca Pharma India Limited | 2.47 Billion INR | 12.088% |
Mankind Pharma Limited | 29.27 Billion INR | 92.572% |
Sequent Scientific Limited | 2.9 Billion INR | 25.064% |
Neuland Laboratories Limited | 2.92 Billion INR | 25.779% |
J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | 85.3% |
Glenmark Pharmaceuticals Limited | 46.95 Billion INR | 95.369% |
Zydus Lifesciences Limited | 125.21 Billion INR | 98.263% |
Amrutanjan Health Care Limited | 2.09 Billion INR | -3.842% |
Wockhardt Limited | 8.48 Billion INR | 74.357% |
Bal Pharma Limited | 555.62 Million INR | -291.36% |
Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 97.732% |
Bliss GVS Pharma Limited | 1.41 Billion INR | -53.218% |
Par Drugs and Chemicals Limited | 58.28 Million INR | -3630.612% |
Shilpa Medicare Limited | 3.33 Billion INR | 34.782% |
Valiant Laboratories Limited | 138.02 Million INR | -1475.394% |
Ajanta Pharma Limited | 30.46 Billion INR | 92.862% |
Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -15199.374% |
Granules India Limited | 10.31 Billion INR | 78.915% |
Medicamen Biotech Limited | 335.16 Million INR | -548.781% |
Syncom Formulations (India) Limited | 345.63 Million INR | -529.136% |
Piramal Enterprises Limited | 63.65 Billion INR | 96.584% |
Torrent Pharmaceuticals Limited | 21.42 Billion INR | 89.849% |
NATCO Pharma Limited | 10.05 Billion INR | 78.38% |
Suven Life Sciences Limited | 109.75 Million INR | -1881.321% |
Krebs Biochemicals & Industries Limited | 46.15 Million INR | -4611.197% |
Strides Pharma Science Limited | 9.16 Billion INR | 76.267% |
Indoco Remedies Limited | 12.06 Billion INR | 81.971% |
Alpa Laboratories Limited | 127.38 Million INR | -1607.097% |
Lasa Supergenerics Limited | 291.17 Million INR | -646.804% |
Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | 29.326% |